PMA supplement
N50510 S130: VITEK 2 GRAM NEGATIVE AST FOR CEFEPIME
FDA PMA supplement · Normal 180 Day Track · Biomerieux Vitek, Inc.
Key facts
| Original PMA | N50510 |
|---|---|
| Supplement number | S130 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | VITEK 2 GRAM NEGATIVE AST FOR CEFEPIME |
| Generic name | Susceptibility test cards, antimicrobial |
| Applicant | Biomerieux Vitek, Inc. |
| Product code | LTW |
| Received date | Apr 3, 2000 |
| Decision date | May 18, 2000 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: